18 May 2013
Keywords: upjohn, antifungal, licensed, rights, market, recordati, lomexin
Article | 12 June 1995
Upjohn has licensed rights to market Recordati's antifungal Lomexin
(fenticonazole) in the UK and Ireland. It is a topical imidazole
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
17 May 2013
© 2013 thepharmaletter.com